NCT02841748 · Interventional trial
A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study
Overall registry status Completed
Phase 2
Conditions Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory